Human Phenotype Ontology

About
MSeqDR-LSDB
Tools
- Quick-Mitome for WES
- Quick-Mitome
- Quick-Mitome Report
- mtDNA Tool:
- mvTool
- Phy-Mer
- MToolBox
- mvTool for Haplogroup
- mvTool with HmtDB
- MitoMaster
- MitoTIP tRNA Scoring
- MSeq-OpenCGA
- Variant Tool:
- VariantOneStop
- HBCR Exome (Retired)
- POLG Patho. Server
- Data - Awsomics GeEx
- Expert Panel
- Panel Tool:
- Gene Panel Examiner
- Transgenomic_NuclearMitome
- Pedigree Maker
- json2table
Phenome-Disease
Collaboration
- Genesis (GEM.App)
- LeighMap
- Expert Panel
- Collaboration Zone
Submission
- Submit_Interpret_Variant
- Instructions

Hello! Guest! Please Login or Register! Clinician Mode

Examples Gene: MT-ND1, POLG, Region: M:1-1000 Variant: m.8993T>G, 1:g.10042757T>C rs3888511 MSCV_0000006, ClinVar: RCV000000015, Disease: Leigh syndrome, Phenotype: Retinopathy

Grandparent Node:
Abnormality of amino acid metabolism (HP:0004337)

Parent Node:
Abnormal circulating aromatic amino acid concentration (HP:0004338)

..Starting node
..Abnormal circulating tyrosine concentration (HP:0010917)

Term ID:

10917

Name:

Abnormal circulating tyrosine concentration

Synonym:

Definition:

Any deviation from the normal concentration of tyrosine in the blood circulation.

Comments:

Reference:

HP:0010917

Genes and Diseases:

Child Nodes:

........

Hypertyrosinemia (HP:0003231)

Sister Nodes:

Abnormal circulating phenylalanine concentration (HP:0010893)

Abnormal circulating tryptophan concentration (HP:0004365)

Input	HPO ID	HPO term	Distance	Gene	Gene id entrez	HGNC ID	DiseaseId	DiseaseName	Frequency	ClinVar variants
HPO disease - gene - phenotype typical associations:
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010917	HP:0010917	Abnormal circulating tyrosine concentration	0	BCS1L CL E G H	617	1020	OMIM:124000	Mitochondrial complex III deficiency, nuclear type 1		72
HP:0010917	HP:0010917	Abnormal circulating tyrosine concentration	0	FAH CL E G H	2184	3579	OMIM:276700	Tyrosinemia, type I		107
HP:0010917	HP:0010917	Abnormal circulating tyrosine concentration	0	HPD CL E G H	3242	5147	ORPHA:2118	Hawkinsinuria	HP:0040281 - Very frequent	23
HP:0010917	HP:0010917	Abnormal circulating tyrosine concentration	0	HPD CL E G H	3242	5147	OMIM:140350	HAWKINSINURIA		23
HP:0010917	HP:0010917	Abnormal circulating tyrosine concentration	0	HPD CL E G H	3242	5147	OMIM:276710	Tyrosinemia, type III		23
HP:0010917	HP:0010917	Abnormal circulating tyrosine concentration	0	PNPO CL E G H	55163	30260	ORPHA:79096	Pyridoxal phosphate-responsive seizures	HP:0040283 - Occasional	92
HP:0010917	HP:0010917	Abnormal circulating tyrosine concentration	0	SLC25A13 CL E G H	10165	10983	ORPHA:247598	Neonatal intrahepatic cholestasis due to citrin deficiency		82
HP:0010917	HP:0010917	Abnormal circulating tyrosine concentration	0	TAT CL E G H	6898	11573	OMIM:276600	Tyrosine transaminase deficiency		43
HP:0010917	HP:0500133	Hypotyrosinemia	1	CL E G H
HP:0010917	HP:0003231	Hypertyrosinemia	1	BCS1L CL E G H	617	1020	OMIM:124000	Mitochondrial complex III deficiency, nuclear type 1		72
HP:0010917	HP:0003231	Hypertyrosinemia	1	FAH CL E G H	2184	3579	OMIM:276700	Tyrosinemia, type I	.	107
HP:0010917	HP:0003231	Hypertyrosinemia	1	HPD CL E G H	3242	5147	OMIM:140350	HAWKINSINURIA	.	23
HP:0010917	HP:0003231	Hypertyrosinemia	1	HPD CL E G H	3242	5147	OMIM:276710	Tyrosinemia, type III	.	23
HP:0010917	HP:0003231	Hypertyrosinemia	1	SLC25A13 CL E G H	10165	10983	ORPHA:247598	Neonatal intrahepatic cholestasis due to citrin deficiency	HP:0040282 - Frequent	82
HP:0010917	HP:0003231	Hypertyrosinemia	1	TAT CL E G H	6898	11573	OMIM:276600	Tyrosine transaminase deficiency	.	43

Genes (6) :BCS1L FAH HPD PNPO SLC25A13 TAT

Diseases (8) :OMIM:124000 OMIM:276700 ORPHA:2118 OMIM:140350 OMIM:276710 ORPHA:79096 ORPHA:247598 OMIM:276600

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.

Feedback about the webpages , or email to MSeqDR webmaster: Lishuang Shen